Altered membrane anisotropy gradients of plasma membranes of living peripheral blood leukocytes in aging and Alzheimer's Disease

https://doi.org/10.1016/0047-6374(91)90081-AGet rights and content

Abstract

Several reports have suggested that membrane rigidity, a term that refers to the relative motion of membrane constituents, is decreased in Alzheimer's Disease. Accordingly, a series of fluorescent membrane probes was used to evaluate the rigidity from the surface to the center of the outer hemi-leaflet of the plasma membrane of living neutrophils, monocytes and lymphocytes. Anisotropy, a parameter which increases with increasing membrane rigidity, was calculated from flow cytometric measurements of vertically and horizontally polarized components of the fluorescence emission of the probes. These preliminary experiments suggest that whereas membrane rigidity in certain regions of the plasma membrane of peripheral blood leukocytes is increased as expected in elderly controls, it is decreased in Alzheimer's disease.

References (59)

  • J.M. Collins et al.

    Shape of the fluidity gradient in the plasma membrane of living HeLa cells

    J. Lipid Res.

    (1990)
  • S.R. Johns et al.

    13C-NMR studies on fluorescent probes: 13C chemical shifts and longitudinal relaxation times of n-hydroxyl-fatty (n = 2,6,9 and 12) acids and n-(9-anthroyloxy)-stearic (n = 6,12) acids

    Chem. Phys. Lipids

    (1979)
  • G.E. Gibson et al.

    Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients

    Biol. Psychiatry

    (1987)
  • E. Bartha et al.

    Altered lymphocyte acetylcholinesterase activity in patients with senile dementia

    Neurosci. Lett.

    (1987)
  • A. Adem et al.

    Extraneural cholinergic markers in Alzheimer's and Parkinson's disease

    Prog. Neurophsychopharmacol. Biol. Psychiatry

    (1986)
  • V.K. Singh et al.

    Binding of corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease

    Immunol. Lett.

    (1988)
  • V.K. Singh et al.

    Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients

    Mech. Ageing Dev.

    (1987)
  • R.M. Torack

    T-lymphocyte function in Alzheimer's disease

    Neurosci. Lett.

    (1986)
  • T.A. Smith et al.

    Radiosensitivity of lymphocytes from patients with Alzheimer's disease

    Mutat. Res.

    (1989)
  • A. Leonardi et al.

    Functional study of T lymphocyte responsiveness in patients with dementia of the Alzheimer type

    J. Neuroimmunol.

    (1989)
  • J.L. Mege et al.

    Phagocytic cell function in aged subjects

    Neurobiol. Aging

    (1988)
  • H. Borochov et al.

    The effect of phosphatidylcholine to sphingomyelin mole ratio on the dynamic properties of sheep erythrocyte membranes

    Biochim. Biophys. Acta.

    (1977)
  • W. Meier-Ruge et al.

    Neurochemical enzyme changes in Alzheimer's and Pick's disease

    Arch. Gerontol. Geriatr.

    (1984)
  • D. Papahadjopoulos et al.

    Role of cholesterol in membranes: effect of phospholipid-protein interactions, membrane permeability and enzymatic activity

    Biochim. Biophys. Acta.

    (1973)
  • R.P. Ebstein et al.

    Age related decline in aluminum-activated human platelet adenylate cyclase: post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer's type

    Life Sci.

    (1986)
  • J.S. Wiley et al.

    Inhibition of cation cotransport by cholesterol enrichment of human red cell membranes

    Biochim. Biophys. Acta.

    (1975)
  • C.D. Stubbs et al.

    The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function

    Biochim. Biophys. Acta.

    (1984)
  • A.A. Spector et al.

    Membrane lipid composition and cellular function

    J. Lipid Res.

    (1985)
  • P.L. Yeagle

    Cholesterol and the cell membrane

    Biochim. Biophys. Acta.

    (1985)
  • Cited by (14)

    • Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery

      2021, Ageing Research Reviews
      Citation Excerpt :

      Abnormal lipid components in the cell membrane affect membrane fluidity and function. Increased membrane fluidity has been observed within and outside the brain (platelets, RBC, lymphocytes, granulocytes, skin fibroblasts, and adrenal medullary cells) in patients with AD and Down syndrome (Collins et al., 1991; Scott et al., 1994; Zubenko et al., 1987; Zubenko and Howland, 1988). Membrane fluidity plays an important role in membrane APP processing, cellular phagocytosis, and membrane-dependent biological functions (endocytosis, phagocytosis, macropinocytosis, and autophagy), all of which affect Aβ peptide metabolism.

    • Considerations for Determining Direct Versus Indirect Functional Effects of Solubilizing Excipients on Drug Transporters for Enhancing Bioavailability

      2020, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Direct interaction between surfactant and polymer molecules with P-gp also appears to be questionable, as other mechanisms such as changes in plasma membrane integrity or in the disruption of mitochondria and inhibition of PKC, which is also membrane bound, have been implicated and elaborated on in the following sections. Clearly the delineation of the potential effects needs to be further examined, for example, fluorescent anisotropy to measure membrane fluidity changes as discussed in the following sections.142-144 P-gp is a transmembrane protein with a duplicated structure containing 6-membrane-spanning segments in each half.145

    View all citing articles on Scopus
    View full text